当前位置: 首页 > 期刊 > 《医药产业资讯》 > 20206
编号:13504175
非酒精性脂肪性肝病的治疗研究进展(5)
http://www.100md.com 2020年2月25日 《中国医药导报》 20206
     [27] Borrelli A,Bonelli P,Tuccillo FM,et al. Role of gut microbiota and oxidative stress in the progression of non-alcoholic fatty liver disease to hepatocarcinoma:Current and innovative therapeutic approaches [J]. Redox Biol,2018,15:467-479.

    [28] Koopman N,Molinaro A,Nieuwdorp M,et al. Review article:can bugs be drugs? The potential of probiotics and prebiotics as treatment for non-alcoholic fatty liver disease [J]. Aliment Pharmacol Ther ......
上一页1 2 3 4 5

您现在查看是摘要页,全文长 2804 字符